DPYD and Fluorouracil-Based Chemotherapy: Mini Review and Case Report

5-Fluorouracil remains a foundational component of chemotherapy for solid tumour malignancies. While considered a generally safe and effective chemotherapeutic, 5-fluorouracil has demonstrated severe adverse event rates of up to 30%. Understanding the pharmacokinetics of 5-fluorouracil can improve t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigle, Theodore J., Tsvetkova, Elena V., Welch, Stephen A., Kim, Richard B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572291/
https://www.ncbi.nlm.nih.gov/pubmed/31052357
http://dx.doi.org/10.3390/pharmaceutics11050199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572291/
https://www.ncbi.nlm.nih.gov/pubmed/31052357
http://dx.doi.org/10.3390/pharmaceutics11050199

Ejemplares similares